Azenta (AZTA) Cash from Financing Activities (2010 - 2026)
Azenta (AZTA) posted quarterly Cash from Financing Activities of -$1.7 million for Q1 2026, up 67.95% year-over-year from -$983642.3 in Q1 2025, and up 37.23% quarter-over-quarter from -$2.6 million in Q4 2025.
Azenta (AZTA) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Azenta (AZTA) has reported Cash from Financing Activities for 17 consecutive years, with -$1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 67.95% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$9.6 million (up 98.02% YoY), while the FY2025 annual figure was -$9.6 million, up 98.55% from the prior year.
- Cash from Financing Activities climbed to -$1.7 million in Q1 2026 per AZTA's latest filing, from -$2.6 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $1.8 million in Q3 2022 and bottomed at -$504.7 million in Q4 2022.
- Historically, Cash from Financing Activities has averaged -$98.1 million across 5 years, with a median of -$30.5 million in 2022.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 139.28% — and 2023, when it sank 16399.04%.
- Azenta's Cash from Financing Activities stood at -$504.7 million in 2022, then surged by 77.58% to -$113.2 million in 2023, then soared by 95.47% to -$5.1 million in 2024, then jumped by 48.65% to -$2.6 million in 2025, then jumped by 37.23% to -$1.7 million in 2026.
- Business Quant data shows AZTA's Cash from Financing Activities at -$1.7 million in Q1 2026, -$2.6 million in Q4 2025, and -$128000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Azenta | 1.69 Bn | 1.37 Bn | 198.10 Mn | -51.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -51.97 Mn |
| Jun 30, 2026 | -51.97 Mn |
| Mar 31, 2026 | -1.65 Mn |
| Mar 31, 2026 | -1.65 Mn |
| Dec 31, 2025 | -2.63 Mn |
| Dec 31, 2025 | -2.63 Mn |
| Jun 30, 2025 | -128,000.00 |
| Jun 30, 2025 | -128,000.00 |
| Mar 31, 2025 | -5.15 Mn |
| Mar 31, 2025 | -5.15 Mn |
| Dec 31, 2024 | -5.13 Mn |
| Dec 31, 2024 | -5.13 Mn |
| Sep 30, 2024 | -247.55 Mn |
| Sep 30, 2024 | -247.55 Mn |
| Jun 30, 2024 | -226.12 Mn |
| Jun 30, 2024 | -226.12 Mn |
| Mar 31, 2024 | -72.39 Mn |
| Mar 31, 2024 | -72.39 Mn |
| Dec 31, 2023 | -113.15 Mn |
| Dec 31, 2023 | -113.15 Mn |